Soluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease

被引：4
作者：
Afangbedji, Nowah [1 ,2 ]
Kumari, Namita [1 ]
Diaz, Sharmin [1 ]
Wen, Fayuan [1 ]
Taylor, James G. [1 ,3 ]
Nekhai, Sergei [1 ,3 ,4 ]
Jerebtsova, Marina [4 ,5 ]
机构：
[1] Howard Univ, Ctr Sickle Cell, Washington, DC USA
[2] Howard Univ, Dept Physiol & Biophys, Washington, DC USA
[3] Howard Univ, Dept Med, Washington, DC USA
[4] Howard Univ, Coll Med, Dept Microbiol, Washington, DC USA
[5] Howard Univ, Coll Med, Dept Microbiol, Room 311,520 St NW, Washington, DC 20059 USA
来源：
BLOOD ADVANCES | 2023年 / 7卷 / 09期
基金：
美国国家卫生研究院;
关键词：
UPAR;
D O I：
10.1182/bloodadvances.2022008374
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1854 / 1857
页数：4
相关论文
共 50 条
  • [31] Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding
    Dupont, Daniel Miotto
    Madsen, Jeppe Buur
    Hartmann, Roland Karl
    Tavitian, Bertrand
    Duconge, Frederic
    Kjems, Jorgen
    Andreasen, Peter Andre
    [J]. RNA, 2010, 16 (12) : 2360 - 2369
  • [32] The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling
    Solberg, H
    Ploug, M
    Hoyer-Hansen, G
    Nielsen, BS
    Lund, LR
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (02) : 237 - 246
  • [33] High concentration of urokinase-type plasminogen activator receptor in the serum of women with primary breast cancer
    Thielemann, Anna
    Baszczuk, Aleksandra
    Kopczynski, Przemyslaw
    Kopczynski, Zygmunt
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (05): : 440 - 445
  • [34] Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells
    Lanza, F
    Castoldi, GL
    Castagnari, B
    Todd, RF
    Moretti, S
    Spisani, S
    Latorraca, A
    Focarile, E
    Roberti, MG
    Traniello, S
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) : 110 - 123
  • [35] Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer
    Illemann, Martin
    Laerum, Ole Didrik
    Hasselby, Jane Preuss
    Thurison, Tine
    Hoyer-Hansen, Gunilla
    Nielsen, Hans Jorgen
    Christensen, Ib Jarle
    [J]. CANCER MEDICINE, 2014, 3 (04): : 855 - 864
  • [36] SLURP-1 Modulates Corneal Homeostasis by Serving as a Soluble Scavenger of Urokinase-Type Plasminogen Activator
    Swamynathan, Sudha
    Swamynathan, Shivalingappa K.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (10) : 6251 - 6261
  • [37] Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria
    Fauser, S
    Deininger, MH
    Kremsner, PG
    Magdolen, V
    Luther, T
    Meyermann, R
    Schluesener, HJ
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2000, 111 (1-2) : 234 - 240
  • [38] Cell Signaling by Urokinase-type Plasminogen Activator Receptor Induces Stem Cell-like Properties in Breast Cancer Cells
    Jo, Minji
    Eastman, Boryana M.
    Webb, Drue L.
    Stoletov, Konstantin
    Klemke, Richard
    Gonias, Steven L.
    [J]. CANCER RESEARCH, 2010, 70 (21) : 8948 - 8958
  • [39] Plasma-soluble urokinase-type plasminogen activator receptor levels are associated with clinical and pathological activities in lupus nephritis: a large cohort study from China
    Qin, D. D.
    Song, D.
    Huang, J.
    Yu, F.
    Zhao, M. H.
    [J]. LUPUS, 2015, 24 (06) : 546 - 557
  • [40] The urokinase-type plasminogen activator system in resected non-small-cell lung cancer
    Salden, M
    Splinter, TAW
    Peters, HA
    Look, MP
    Timmermans, M
    van Meerbeeck, JPAM
    Foekens, JA
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (03) : 327 - 332
12345